Absence of PTEN/MMAC1 Pseudogene in Mice

Kwabi-Addo, Bernard; Thompson, Timothy C.; Ittmann, Michael
May 2000
DNA & Cell Biology;May2000, Vol. 19 Issue 5, p301
Academic Journal
The PTEN gene encodes a phosphatase that acts as a tumor-suppressor gene and is mutated in a variety of human cancers. Alterations of the PTEN gene in these tumor samples were identified using exon-by-exon analysis of the gene using single-stranded conformational polymorphism or direct sequencing of PTEN cDNA. However, in humans, mutational analysis of a PTEN cDNA template can produce false results because of a highly conserved PTEN processed pseudogene that shares more than 98% homology with the coding region of functional PTEN. PTEN-knockout mice develop tumors, suggesting that mouse tumor models are useful in vivo model systems to study PTEN function. Any mutational analysis of mouse PTEN cDNA may also produce false results if mice contain a highly conserved PTEN pseudogene. In this paper, we demonstrate the absence of any PTEN pseudogene in the mouse and discuss the significance of this observation for the mutational studies of the PTEN gene in mouse tumor models.


Related Articles

  • Size and sequence polymorphism in the isocitrate dehydrogenase kinase/phosphatase gene (aceK)... Nelson, Kimberlyn; Wang, Fu-Sheng // Genetics;Dec97, Vol. 147 Issue 4, p1509 

    Presents a study on the genetic sequence involved in the polymorphism relating to phosphatase gene (aceK) in Salmonella enterica and Escherichia coli. Description of gene; Recovery of population genetic studies of sequence variation in several genes; Controlling of represented expression of the...

  • The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Iuliano, Rodolfo; Pera, Ilaria Le; Cristofaro, Carmela; Baudi, Francesco; Arturi, Franco; Pallante, PierLorenzo; Martelli, Maria Luisa; Trapasso, Francesco; Chiariotti, Lorenzo; Fusco, Alfredo // Oncogene;11/4/2004, Vol. 23 Issue 52, p8432 

    We recently isolated the r-PTPeta gene, which encodes a receptor-type tyrosine phosphatase protein that suppresses the neoplastic phenotype of retrovirally transformed rat thyroid cells. The human homologue gene PTPRJ/DEP-1 is deleted in various tumors. Moreover, the Gln276Pro polymorphism,...

  • Functional Genetic Polymorphisms in PP2A Subunit Genes Confer Increased Risks of Lung Cancer in Southern and Eastern Chinese. Yang, Rongrong; Yang, Lei; Qiu, Fuman; Zhang, Lisha; Wang, Hui; Yang, Xiaorong; Deng, Jieqiong; Fang, Wenxiang; Zhou, Yifeng; Lu, Jiachun // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Protein phosphatase-2A (PP2A) is one of the major cellular serine-threonine phosphatases and functions as a tumor suppressor that negatively regulates the activity of some oncogenic kinases. Recent studies have reported that PP2A expression was suppressed during lung carcinogenesis, we there...

  • Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Liu, G; Ghadirian, P; Vesprini, D; Hamel, N; Paradis, A-J; Lal, G; Gallinger, S; Narod, S A; Foulkes, W D // British Journal of Cancer;5/15/2000, Vol. 82 Issue 10, p1646 

    A prospective study of 149 unselected incident cases of pancreatic adenocarcinoma and 146 ethnically-matched controls found no associations between GSTM1 (adjusted odds ratio (AOR) 1.14), GSTT1 (AOR: 1.19) and CYP1A1 (AOR: 1.08) polymorphisms and pancreatic cancer susceptibility. Smoking and...

  • Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV. Tokushige, Katsutoshi; Tsuchiya, Noriko; Hasegawa, Kiyoshi; Hashimoto, Etsuko; Yamauchi, Katsumi; Komatsu, Tatsuzi; Hayashi, Naoaki // American Journal of Gastroenterology;Jan2003, Vol. 98 Issue 1, p160 

    : ObjectiveTo clarify the host genomic role in chronic liver disease associated with hepatitis C virus (HCV), we investigated the relationship between the severity of hepatitis and the polymorphisms of the tumor necrosis factor (TNF) gene or the human leukocyte antigen (HLA)-DRB1 haplotypes.:...

  • A bi-allelic VNTR in the human TNFR2 (p75) gene promoter. Keen, L; Wood, N; Olomolaiye, O; Bidwell, J // Genes & Immunity;Nov99, Vol. 1 Issue 2, p164 

    We describe a bi-allelic VNTR polymorphism within a 42 bp region in the promoter of the tumour necrosis factor receptor 2 gene (TNFR2). Within this region there are one (Allele 1) or two (Allele 2) repeats of a 15 bp sequence, 5'-GCCGGGC AGGTGGAG-3'. Allele frequencies observed in a Caucasian...

  • Role of genetic polymorphisms in tumour angiogenesis. Balasubramanian, S.P.; Brown, N.J.; Reed, M.W.R. // British Journal of Cancer;11/01/2002, Vol. 87 Issue 10, p1057 

    Discusses the role of genetic polymorphisms in tumor angiogenesis. Abnormal expression of pro- and anti-angiogenic factors in tumors, influencing tumor angiogenesis, growth and progression; Genetic polymorphisms in angiogenic genes and relevance to cancer care; Description of vascular...

  • Tamoxifen: drug interactions involving CYP2D6 genetic variants.  // WHO Drug Information;2010, Vol. 24 Issue 4, p303 

    The article reports on British research which found that CYP2D6 genetic polymorphisms and concomitant use of potent CYP2D6 inhibitors may be associated with variability in clinical response in patients treated with tamoxifen for breast cancer.

  • Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma. Nakahara, Y; Nagai, H; Kinoshita, T; Uchida, T; Hatano, S; Murate, T; Saito, H // Leukemia (08876924);Aug98, Vol. 12 Issue 8, p1277 

    The PTEN/MMAC1 gene at 10q23.3, which has dual specific phosphatase activity, is a novel tumor suppressor gene candidate. Various kinds of tumors have mutations in this gene, including glioblastoma, endometrial carcinoma and prostate cancer. We examined 29 cases of primary non-Hodgkin's lymphoma...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics